Cargando…

The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases

The treatment of memory impairments associated with the central nervous system diseases remains an unmet medical need with social and economic implications. Here we show, that a multi-target ligand of aminergic G protein-coupled receptors with antipsychotic activity in vivo (D2AAK1) stimulates neuro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koszła, Oliwia, Sołek, Przemysław, Woźniak, Sylwia, Kędzierska, Ewa, Wróbel, Tomasz M., Kondej, Magda, Archała, Aneta, Stępnicki, Piotr, Biała, Grażyna, Matosiuk, Dariusz, Kaczor, Agnieszka A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700684/ https://www.ncbi.nlm.nih.gov/pubmed/33238370 http://dx.doi.org/10.3390/ijms21228849

Ejemplares similares

Screening and Structure–Activity Relationship of D2AAK1 Derivatives for Potential Application in the Treatment of Neurodegenerative Diseases
por: Koszła, Oliwia, et al.
Publicado: (2022)

Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes
por: Bartuzi, Damian, et al.
Publicado: (2022)

Current Approaches and Tools Used in Drug Development against Parkinson’s Disease
por: Koszła, Oliwia, et al.
Publicado: (2021)

N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic
por: Kaczor, Agnieszka A., et al.
Publicado: (2020)

Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1H-indole (D2AAK1_3) as Dopamine D(2) Receptor Ligand
por: Kondej, Magda, et al.
Publicado: (2018)

Synthesis, Structural and Behavioral Studies of Indole Derivatives D2AAK5, D2AAK6 and D2AAK7 as Serotonin 5-HT(1A) and 5-HT(2A) Receptor Ligands
por: Kaczor, Agnieszka A., et al.
Publicado: (2023)

Synthesis of Novel 2-(Cyclopentylamino)thiazol-4(5H)-one Derivatives with Potential Anticancer, Antioxidant, and 11β-HSD Inhibitory Activities
por: Baumgart, Szymon, et al.
Publicado: (2023)

Current Concepts and Treatments of Schizophrenia
por: Stępnicki, Piotr, et al.
Publicado: (2018)

Multi-Target Approach for Drug Discovery against Schizophrenia
por: Kondej, Magda, et al.
Publicado: (2018)

In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
por: Koszła, Oliwia, et al.
Publicado: (2020)

Allosteric modulation of dopamine D(2L) receptor in complex with G(i1) and G(i2) proteins: the effect of subtle structural and stereochemical ligand modifications
por: Żuk, Justyna, et al.
Publicado: (2022)

Overcoming Depression with 5-HT(2A) Receptor Ligands
por: Zięba, Agata, et al.
Publicado: (2021)

Synthesis, central nervous system activity, and structure–activity relationship of 1-aryl-6-benzyl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones
por: Rządkowska, Marzena, et al.
Publicado: (2014)

Synthesis, Central Nervous System Activity and Structure-Activity Relationships of Novel 1-(1-Alkyl-4-aryl-4,5-dihydro-1H-imidazo)-3-substituted Urea Derivatives
por: Szacoń, Elżbieta, et al.
Publicado: (2015)

Novel Positive Allosteric Modulators of µ Opioid Receptor—Insight from In Silico and In Vivo Studies
por: Bartuzi, Damian, et al.
Publicado: (2020)

Synthesis and Pharmacological Evaluation of Novel 1-(1,4-Alkylaryldisubstituted-4,5-dihydro-1H-imidazo)-3-substituted Urea Derivatives
por: Szacoń, Elżbieta, et al.
Publicado: (2016)

Aak to Zumbra : a dictionary of the world's watercraft /
Publicado: (2000)

Development and Characterization of Novel Selective, Non-Basic Dopamine D(2) Receptor Antagonists for the Treatment of Schizophrenia
por: Stępnicki, Piotr, et al.
Publicado: (2023)

Neuronal life or death linked to depression treatment: the interplay between drugs and their stress-related outcomes relate to single or combined drug therapies
por: Solek, Przemyslaw, et al.
Publicado: (2019)

Dysfunction of Endocytic Kinase AAK1 in ALS
por: Shi, Bingxing, et al.
Publicado: (2014)

Toxicity of Carlina Oxide—A Natural Polyacetylene from the Carlina acaulis Roots—In Vitro and in Vivo Study
por: Wnorowski, Artur, et al.
Publicado: (2020)

Synthesis and molecular docking of novel non-competitive antagonists of GluK2 receptor
por: Kaczor, Agnieszka A., et al.
Publicado: (2014)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Synthesis, Structural Studies and Molecular Modelling of a Novel Imidazoline Derivative with Antifungal Activity
por: Wróbel, Tomasz M., et al.
Publicado: (2015)

Comparative molecular field analysis and molecular dynamics studies of the dopamine D(2) receptor antagonists without a protonatable nitrogen atom
por: Kaczor, Agnieszka A., et al.
Publicado: (2018)

Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors
por: Bartuzi, Damian, et al.
Publicado: (2017)

The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery
por: Zięba, Agata, et al.
Publicado: (2023)

Experimental and Computational Structural Studies of 2,3,5-Trisubstituted and 1,2,3,5-Tetrasubstituted Indoles as Non-Competitive Antagonists of GluK1/GluK2 Receptors
por: Bartyzel, Agata, et al.
Publicado: (2022)

Thyroid Peroxidase Activity is Inhibited by Phenolic Compounds—Impact of Interaction
por: Habza-Kowalska, Ewa, et al.
Publicado: (2019)

Preferential Coupling of Dopamine D(2S) and D(2L) Receptor Isoforms with G(i1) and G(i2) Proteins—In Silico Study
por: Żuk, Justyna, et al.
Publicado: (2020)

An attempt to optimize the outcome of penetrating keratoplasty in congenital aniridia-associated keratopathy (AAK)
por: Farah, C. J., et al.
Publicado: (2021)

Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors
por: Bartuzi, Damian, et al.
Publicado: (2017)

Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosis
por: Conner, Sean D., et al.
Publicado: (2002)

Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain
por: Kostich, Walter, et al.
Publicado: (2016)

lncRNA ZFAS1 promotes intervertebral disc degeneration by upregulating AAK1
por: Wang, Zheng, et al.
Publicado: (2022)

A common variant in AAK1 reduces risk of noise-induced hearing loss
por: Wang, Qixuan, et al.
Publicado: (2023)

Effect of Commonly Used Cosmetic Preservatives on Healthy Human Skin Cells
por: Głaz, Patrycja, et al.
Publicado: (2023)

The Val34Met, Thr164Ile and Ser220Cys Polymorphisms of the β2-Adrenergic Receptor and Their Consequences on the Receptor Conformational Features: A Molecular Dynamics Simulation Study
por: Archala, Aneta, et al.
Publicado: (2022)

Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer
por: Ganapathi, Ram N., et al.
Publicado: (2020)

The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists
por: Zięba, Agata, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lf0vqkj56i43idgf730qr4meuk